Aptium Oncology   Report issue

For profit Phase 2
Founded: Westlake Village CA United States (1983)
Status: No NME R&D (1983)

Organization Overview

First Clinical Trial
2005
NCT00129844
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Aptium Oncology Gastrointestinal Cancer Consortium | Aptium Oncology, Inc. Cedars-Sinai Outpatient Cancer Center | Aptium Oncology Research Network | CMO Aptium Oncology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Colorectal Neoplasms (Phase 2)

Lung Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4